Literature DB >> 22981642

Spontaneous brachial pseudo-aneurysm in a 12-year-old with kyphoscoliosis-type Ehlers-Danlos Syndrome.

E Gok1, O S Goksel, U Alpagut, E Dayioglu.   

Abstract

The Ehlers-Danlos Syndrome (EDS) is a rare connective tissue disorder characterised by fragility of the soft connective tissues and widespread manifestations in skin, ligaments, joints, blood vessels and internal organs. We report a case of a 12-year-old boy, previously diagnosed with kyphoscoliosis-type EDS (type VI), presenting with a left brachial artery pseudo-aneursym with history of multiple spontaneous and post-traumatic arterial ruptures. Surgical management of this patient was performed successfully by primary repair of brachial artery lesion.
Copyright © 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22981642     DOI: 10.1016/j.ejvs.2012.08.004

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  4 in total

1.  Arterial fragility in kyphoscoliotic Ehlers-Danlos syndrome.

Authors:  Pierrick Henneton; Anne Legrand; Cecilia Giunta; Michael Frank
Journal:  BMJ Case Rep       Date:  2018-07-06

2.  Visceral artery aneurysms: Incidence, management, and outcome analysis in a tertiary care center over one decade.

Authors:  Michael B Pitton; Evelyn Dappa; Florian Jungmann; Roman Kloeckner; Sebastian Schotten; Gesine M Wirth; Jens Mittler; Hauke Lang; Peter Mildenberger; Karl-Friedrich Kreitner; Katja Oberholzer; Christoph Dueber
Journal:  Eur Radiol       Date:  2015-02-19       Impact factor: 5.315

3.  Congenital Chylous Ascites and Ehlers-Danlos Syndrome Type VI.

Authors:  Anna K Ermarth; John Pohl; Brittany Esty; Jessica K Sempler; John C Carey; Molly A O'Gorman
Journal:  ACG Case Rep J       Date:  2016-12-21

Review 4.  Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review.

Authors:  Sanne D'hondt; Tim Van Damme; Fransiska Malfait
Journal:  Genet Med       Date:  2017-10-05       Impact factor: 8.822

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.